Terms: = Pancreatic cancer AND TRIP11, Q15643, 9321, ENSG00000100815, Trip230, CEV14 AND Prognosis
2 results:
1. A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma.
Zhang T; Zhang S; Jin C; Lin Z; Deng T; Xie X; Deng L; Li X; Ma J; Ding X; Liu Y; Shan Y; Yu Z; Wang Y; Chen G; Li J
Front Cell Infect Microbiol; 2021; 11():751795. PubMed ID: 34888258
[TBL] [Abstract] [Full Text] [Related]
2. Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials.
Ottaiano A; Capozzi M; De Divitiis C; De Stefano A; Botti G; Avallone A; Tafuto S
Acta Oncol; 2017 Mar; 56(3):377-383. PubMed ID: 28256961
[TBL] [Abstract] [Full Text] [Related]
